TY - JOUR
T1 - Sex Differences in Influenza
T2 - The Challenge Study Experience
AU - Giurgea, Luca T.
AU - Cervantes-Medina, Adriana
AU - Walters, Kathie Anne
AU - Scherler, Kelsey
AU - Han, Alison
AU - Czajkowski, Lindsay M.
AU - Baus, Holly Ann
AU - Hunsberger, Sally
AU - Klein, Sabra L.
AU - Kash, John C.
AU - Taubenberger, Jeffery K.
AU - Memoli, Matthew J.
N1 - Publisher Copyright:
© 2021 Published by Oxford University Press for the Infectious Diseases Society of America 2021.
PY - 2022/2/15
Y1 - 2022/2/15
N2 - Background: Preclinical animal studies and retrospective human studies suggest that adult females have worse outcomes from influenza than males. Prospective studies in humans are missing. Methods: Data from 164 healthy volunteers who underwent influenza A/California/04/2009/H1N1 challenge were compiled to compare differences between sexes. Baseline characteristics, including hormone levels, hemagglutination inhibition (HAI) titers, neuraminidase inhibition (NAI) titers, and outcomes after challenge were compared. Linear and logistic regression models were built to determine significant predictor variables with respect to outcomes of interest. Results: HAI titers were similar between the sexes, but NAI titers were higher in males than females at 4 weeks and 8 weeks postchallenge. Females were more likely to have symptoms (mean, 0.96 vs 0.80; P=.003) and to have a higher number of symptoms (median, 3 vs 4; P=.011) than males. Linear and logistic regression models showed that prechallenge NAI titers, but not HAI titers or sex hormone levels, were predictive of all shedding and symptom outcomes of interest. Conclusions: Females in our cohorts were more likely to be symptomatic and to have a higher number of symptoms than males. NAI titers predicted all outcomes of interest and may explain differential outcomes between the sexes.
AB - Background: Preclinical animal studies and retrospective human studies suggest that adult females have worse outcomes from influenza than males. Prospective studies in humans are missing. Methods: Data from 164 healthy volunteers who underwent influenza A/California/04/2009/H1N1 challenge were compiled to compare differences between sexes. Baseline characteristics, including hormone levels, hemagglutination inhibition (HAI) titers, neuraminidase inhibition (NAI) titers, and outcomes after challenge were compared. Linear and logistic regression models were built to determine significant predictor variables with respect to outcomes of interest. Results: HAI titers were similar between the sexes, but NAI titers were higher in males than females at 4 weeks and 8 weeks postchallenge. Females were more likely to have symptoms (mean, 0.96 vs 0.80; P=.003) and to have a higher number of symptoms (median, 3 vs 4; P=.011) than males. Linear and logistic regression models showed that prechallenge NAI titers, but not HAI titers or sex hormone levels, were predictive of all shedding and symptom outcomes of interest. Conclusions: Females in our cohorts were more likely to be symptomatic and to have a higher number of symptoms than males. NAI titers predicted all outcomes of interest and may explain differential outcomes between the sexes.
KW - Estrogen
KW - Hemagglutinin
KW - Influenza
KW - Neuraminidase
KW - Sex differences
KW - Testosterone
UR - http://www.scopus.com/inward/record.url?scp=85123173088&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123173088&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiab422
DO - 10.1093/infdis/jiab422
M3 - Article
C2 - 34423369
AN - SCOPUS:85123173088
SN - 0022-1899
VL - 225
SP - 715
EP - 722
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 4
ER -